We are looking at doubling revenues in the next three to four years. We have about seven to eight products in our R&D pipeline. We stick to philosophies of integration. We made IB because it is the raw material for ATBS, then we thought what next can we do it? We are setting up a plant to make butylphenol.
Original source: https://health.economictimes.indiatimes.com/news/pharma/butylphenol-to-be-vinati-organics-growth-driver-for-next-2-3-years-vinati-saraf-mutreja/73039032?utm_source=RSS&utm_medium=ETRSS